Results 161 to 170 of about 25,511 (229)

TikTok content on measles-rubella vaccine in Jordan: A cross-sectional study highlighting the spread of vaccine misinformation. [PDF]

Narra J
Abdaljaleel M, Barakat M, Mahafzah A, Hallit R, Hallit S, Sallam M.   +5 more
europepmc   +1 more source

Measles & Rubella Initiative annual report 2013

The Measles and Rubella Initiative (M&RI) is pleased to present our 2013 annual report on the global status of measles and rubella control and elimination.

core  

A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial. [PDF]

Lancet
Adigweme I, Yisa M, Ooko M, Akpalu E, Bruce A, Donkor S, Jarju LB, Danso B, Mendy A, Jeffries D, Segonds-Pichon A, Njie A, Crooke S, El-Badry E, Johnstone H, Royals M, Goodson JL, Prausnitz MR, McAllister DV, Rota PA, Henry S, Clarke E.   +21 more
europepmc   +1 more source

Manual for the surveillance of vaccine-preventable diseases

Chapter 14 of: Manual for the surveillance of vaccine-preventable diseases. 5th edition, 2012.Rubella is a viral illness caused by a togavirus of the genus Rubivirus and is characterized by a mild, maculopapular rash.

core  

Long-term Neutralizing Antibody Levels Against Measles and Rubella Viruses Among Adults With 3 Doses of Measles-Mumps-Rubella Vaccine. [PDF]

Open Forum Infect Dis
Alonge OD, Marin M, Hickman CJ, Sowers SB, Chen MH, Hao L, Mercader S, El-Badry E, McClure DL, Icenogle JP, Sugerman DE, Crooke SN, Nguyen HQ.   +12 more
europepmc   +1 more source

Reply to Özdemir, "Measles-Mumps-Rubella Vaccine and COVID-19 Relationship". [PDF]

mBio, 2020
Fidel PL, Noverr MC.
europepmc   +1 more source

A Randomised Single-Blind Controlled Trial Comparing Efficacy of Intralesional Vitamin D Injection and MMR (Measles, Mumps, Rubella) Vaccine in Treatment of Warts.

Indian J Dermatol
Singh S, Pal S, De A.
europepmc   +1 more source

THE EFFECT OF THE MEASLES, MUMPS AND RUBELLA VACCINE ON INNATE AND ADAPTIVE IMMUNE RESPONSES IN PERSONS RECEIVING A SARS-COV-2 mRNA VACCINE

, 2022
Toit Ld, Gupta A, Dehbi H, Darling TL, Urusova DV, Thirunavukkarasu S, Boon AC, Dubberke ER, Yun L, McKinnon S, DeSchryver AK, Swan B, Netea MG, Khader S, Avidan MS.   +14 more
europepmc   +1 more source